The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(3-(2-chlorophenyl)ureido)-1H-pyrazol-1-yl)-N-(oxetan-3-yl)thiophene-2-carboxamide ID: ALA4753641
PubChem CID: 155803727
Max Phase: Preclinical
Molecular Formula: C18H16ClN5O3S
Molecular Weight: 417.88
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cnn(-c2csc(C(=O)NC3COC3)c2)c1)Nc1ccccc1Cl
Standard InChI: InChI=1S/C18H16ClN5O3S/c19-14-3-1-2-4-15(14)23-18(26)22-11-6-20-24(7-11)13-5-16(28-10-13)17(25)21-12-8-27-9-12/h1-7,10,12H,8-9H2,(H,21,25)(H2,22,23,26)
Standard InChI Key: FPVKFPPNOMNINZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
43.9288 -22.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9277 -23.4904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6357 -23.8993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3454 -23.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3425 -22.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6339 -22.2620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.0537 -23.8974 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
44.6355 -24.7165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9277 -25.1249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2201 -24.7162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9275 -25.9421 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.5123 -25.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7667 -24.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2198 -25.4022 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.6282 -26.1101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4275 -25.9402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2945 -26.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4951 -27.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4096 -27.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1561 -28.1726 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.7029 -27.5653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7018 -28.2485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7017 -29.0657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.9942 -27.8398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9943 -27.0226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5711 -26.4464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9934 -25.8684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.4154 -26.4462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
3 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 12 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 17 2 0
15 17 1 0
19 22 1 0
22 23 2 0
22 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 417.88Molecular Weight (Monoisotopic): 417.0662AlogP: 3.36#Rotatable Bonds: 5Polar Surface Area: 97.28Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.54CX Basic pKa: 0.75CX LogP: 2.64CX LogD: 2.64Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -2.28
References 1. Feng Y,Park H,Bauer L,Ryu JC,Yoon SO. (2021) Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors., 12 (1.0): [PMID:33488960 ] [10.1021/acsmedchemlett.0c00533 ] 2. Feng Y, Park H, Ryu JC, Yoon SO.. (2021) N -Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors., 12 (10.0): [PMID:34676036 ] [10.1021/acsmedchemlett.1c00334 ]